Glioblastoma
Glioblastoma
Definition
The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma, IDH-mutant), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma, IDH- wildtype). (Adapted from WHO)
Also known as GBM, GBM (glioblastoma), glioblastoma, glioblastoma (disease), glioblastoma multiforme, glioblastoma multiforme (disease), grade IV astrocytic neoplasm, grade IV astrocytic tumor, grade IV astrocytic tumour, grade IV astrocytoma, spongioblastoma multiforme, WHO grade IV glioma — per MONDO
Also identified as
- DOID 3068 per MONDO
- MESH D005909 per MONDO
- NCIT C3058 per MONDO
- Orphanet 360 per MONDO
- SCTID 393563007 per MONDO
- UMLS C0017636 per MONDO
Affected Organs
| Organ | Involvement | Source |
|---|---|---|
| Central nervous system | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
| Central nervous system | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
| Nervous system | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
Drugs indicated
| Drug | Relation | Source |
|---|---|---|
| Bevacizumab | may treat | MEDRT · Public domain (U.S. Government work) |
| Carmustine | may treat | MEDRT · Public domain (U.S. Government work) |
| Temozolomide | may treat | MEDRT · Public domain (U.S. Government work) |